GF
BMY icon

Gabelli Funds’s Bristol-Myers Squibb BMY Stock Holding History

Gabelli Funds’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-100
Closed -$2.65M – 1157
2019
Q1 		$2.65M Buy
+100
New +$4.98K 0.02% 694

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Gabelli Funds's BMY Position: Q2 2026 in Review

Gabelli Funds reduced its Bristol-Myers Squibb (BMY) stake by 2.6% in Q2 2026, selling an estimated $401K and leaving 256,790 shares worth $14.8M. The position accounts for 0.09% of the portfolio, ranked #262.

Gabelli Funds first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $79M in Q2 2016. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Gabelli Funds held 256,790 shares of Bristol-Myers Squibb worth $14.8M as of Q2 2026.
  • Gabelli Funds sold 6,990 Bristol-Myers Squibb shares in Q2 2026, an estimated $401K.
  • Bristol-Myers Squibb made up 0.09% of Gabelli Funds's portfolio in Q2 2026, its #262 holding.
  • Gabelli Funds first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Gabelli Funds's Bristol-Myers Squibb position peaked at $79M in Q2 2016.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.